Immunohistochemical analysis also showed that significant expression of PMP22 in 29/48 (60%) of GC tissues, with expression levels that were higher in GC than that in adjacent noncancerous gastric tissues (Fig. 1D). Here, PMP22 is linked to gastric cancer.